Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants

被引:36
作者
Vallin, Melanie [1 ]
Sturm, Nathalie [2 ]
Lamblin, Geraldine [3 ]
Guillaud, Olivier [1 ]
Hilleret, Marie-Noelle [4 ]
Hervieu, Valerie [5 ]
Joubert, Juliette [6 ]
Abergel, Armand [3 ]
Leroy, Vincent [4 ]
Boillot, Olivier [1 ]
Dumortier, Jerome [1 ]
Scoazec, Jean-Yves [5 ]
机构
[1] Hop Edouard Herriot, Hosp Civils Lyon, Lyon, France
[2] Hop A Michallon, CHU Grenoble, Serv Anat Patol, La Tronche, France
[3] Hop Hotel Dieu, CHU Clermont Ferrand, Serv Hepatogastroenterol, Clermont Ferrand, France
[4] Hop A Michallon, CHU Grenoble, Serv Hepatogastroenterol, La Tronche, France
[5] Hop Edouard Herriot, Hosp Civils Lyon, Serv Cent Anat & Cytol Pathol, F-69437 Lyon 03, France
[6] Hop Hotel Dieu, CHU Clermont Ferrand, Serv Anat Patol, Clermont Ferrand, France
关键词
cholangiocarcinoma; cirrhosis; liver transplantation; outcome; recurrence; survival; HEPATOCELLULAR-CARCINOMA; RISK-FACTORS; TRANSPLANTATION; RECURRENCE; CRITERIA; OUTCOMES;
D O I
10.1111/ctr.12108
中图分类号
R61 [外科手术学];
学科分类号
摘要
Liver cirrhosis is a recognized risk factor for intrahepatic cholangiocarcinoma (I-CCa). Small I-CCa nodules might be undiagnosed or misdiagnosed as hepatocellular carcinoma (HCC) in the context of liver cirrhosis. The aim of this study was to determine the prevalence and clinical impact of undetected I-CCa in liver explants of adult cirrhotic patients undergoing liver transplantation (LT). From December 1985 to November 2008, a first LT was performed in 993 adult cirrhotic patients in three French academic Hospitals. All liver explants were analyzed for the presence of nodules. The diagnosis of HCC was made in 331 cases (33.3% of the patients). Similarly, an I-CCa was identified in 10 (1%) patients, with a mean size of 31 +/- 17mm. The mean age at transplantation was 58.8yr (range 45 - 66), and all the patients were men. The mean follow-up after LT was 33months (range 4-52). Post-transplant tumor recurrence was observed in five patients (50%), after a mean delay of 10months. All five patients died. Malignant recurrence was associated with the presence of venous emboli on liver explants. Our results suggest that unrecognized I-CCa complicating liver cirrhosis is a rare entity, associated with high risk of recurrence and poor prognosis.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 22 条
  • [1] Outcomes and Diagnostic Challenges Posed by Incidental Cholangiocarcinoma After Liver Transplantation
    Ali, Jason M.
    Bonomo, Luca
    Brais, Rebecca
    Griffiths, William J. H.
    Lomas, David J.
    Huguet, Emmanuel L.
    Praseedom, Raaj K.
    Jamieson, Neville V.
    Jah, Asif
    [J]. TRANSPLANTATION, 2011, 91 (12) : 1392 - 1397
  • [2] [Anonymous], 2010, WHO Classification of tumors of the digestive system
  • [3] Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period
    Becker, Natasha S.
    Rodriguez, Joel A.
    Barshes, Neal R.
    O'Mahony, Christine A.
    Goss, John A.
    Aloia, Thomas A.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (01) : 117 - 122
  • [4] Predicting Recurrence After Liver Transplantation in Patients with Hepatocellular Carcinoma Exceeding the Up-To-Seven Criteria
    D'Amico, Francesco
    Schwartz, Myron
    Vitale, Alessandro
    Tabrizian, Parissa
    Roayaie, Sasan
    Thung, Swan
    Guido, Maria
    Martin, Juan del Rio
    Schiano, Thomas
    Cillo, Umberto
    [J]. LIVER TRANSPLANTATION, 2009, 15 (10) : 1278 - 1287
  • [5] Needle tract recurrence of hepatocellular carcinoma after liver transplantation
    Dumortier, J
    Lombard-Bohas, C
    Valette, PJ
    Boillot, O
    Scoazec, JY
    Berger, F
    Claudel-Bonvoisin, S
    [J]. GUT, 2000, 47 (02) : 301 - 301
  • [6] PROPOSAL FOR STANDARDIZED CRITERIA FOR THE DIAGNOSIS OF BENIGN, BORDERLINE, AND MALIGNANT HEPATOCELLULAR LESIONS ARISING IN CHRONIC ADVANCED LIVER-DISEASE
    FERRELL, LD
    CRAWFORD, JM
    DHILLON, AP
    SCHEUER, PJ
    NAKANUMA, Y
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (11) : 1113 - 1123
  • [7] Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
    Khan, S. A.
    Toledano, M. B.
    Taylor-Robinson, S. D.
    [J]. HPB, 2008, 10 (02) : 77 - 82
  • [8] Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma
    Kneteman, NM
    Oberholzer, J
    Al Saghier, M
    Meeberg, GA
    Blitz, M
    Ma, MM
    Wong, WWS
    Gutfreund, K
    Mason, AL
    Jewell, LD
    Shapiro, AMJ
    Bain, VG
    Bigam, DL
    [J]. LIVER TRANSPLANTATION, 2004, 10 (10) : 1301 - 1311
  • [9] Kobayashi M, 2000, CANCER, V88, P2471, DOI 10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO
  • [10] 2-T